Trade in the amphetamine-type stimulant captagon in the Middle East grew exponentially in 2021 to top $5 billion, posing an increasing health and security risk to the region, a report said. Research by the New Lines Institute, to be released Tuesday and seen by AFP, paints an alarming picture of the impact booming captagon production is having on the region. "The captagon trade is a rapidly growing illicit economy in ...